Nasal Spray Significantly Accelerates Respiratory Virus Clearance in Phase 2a Clinical Study

MELBOURNE, Australia, Feb. 14 (Korea Bizwire) – ENA Respiratory, a clinical-stage pharmaceutical company, announced that INNA-051, a first-in-class, broad-spectrum, innate immunomodulator in development for the prophylaxis of respiratory viral infections, was found to significantly impact the course of viral infection in a Phase 2a flu challenge study. The study included 123 adults (ages 19 to 53) [...]